ICAD Inc
NASDAQ:ICAD

Watchlist Manager
ICAD Inc Logo
ICAD Inc
NASDAQ:ICAD
Watchlist
Price: 3.87 USD 3.75% Market Closed
Market Cap: $106.3m

Net Margin

-26.8%
Current
Improving
by 9.2%
vs 3-y average of -35.9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-26.8%
=
Net Income
$-5.2m
/
Revenue
$19.5m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-26.8%
=
Net Income
$-5.2m
/
Revenue
$19.5m

Peer Comparison

Country Company Market Cap Net
Margin
US
ICAD Inc
NASDAQ:ICAD
105.2m USD
Loading...
US
Veeva Systems Inc
NYSE:VEEV
35.6B USD
Loading...
US
Cerner Corp
LSE:0R00
31.3B USD
Loading...
AU
Pro Medicus Ltd
ASX:PME
18.8B AUD
Loading...
JP
M3 Inc
TSE:2413
1.3T JPY
Loading...
US
Doximity Inc
NYSE:DOCS
7.3B USD
Loading...
SE
Sectra AB
STO:SECT B
43.4B SEK
Loading...
US
Waystar Holding Corp
NASDAQ:WAY
4.9B USD
Loading...
CN
Winning Health Technology Group Co Ltd
SZSE:300253
24.7B CNY
Loading...
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
265.4B INR
Loading...
US
Vocera Communications Inc
F:V00
2.4B EUR
Loading...

Market Distribution

Lower than 77% of companies in the United States of America
Percentile
23rd
Based on 15 072 companies
23rd percentile
-26.8%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

ICAD Inc
Glance View

Market Cap
106.3m USD
Industry
Health Care

iCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions. The company is headquartered in Nashua, New Hampshire and currently employs 136 full-time employees. The firm operates through two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). In the Detection segment, the Company’s solutions include advanced image analysis and workflow solutions enables healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, and a comprehensive range of artificial intelligence and computer aided detection (CAD) systems and workflow solutions for two-dimension(2D) and third dimension (3D) mammography, magnetic resonance imaging (MRI) and computed tomography (CT). In the Therapy segment, the Company offers the Xoft System, an isotope-free cancer treatment platform technology. The Xoft System can be used for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.

ICAD Intrinsic Value
1.03 USD
Overvaluation 73%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-26.8%
=
Net Income
$-5.2m
/
Revenue
$19.5m
What is ICAD Inc's current Net Margin?

The current Net Margin for ICAD Inc is -26.8%, which is above its 3-year median of -35.9%.

How has Net Margin changed over time?

Over the last 3 years, ICAD Inc’s Net Margin has increased from -40.4% to -26.8%. During this period, it reached a low of -69.8% on Mar 31, 2023 and a high of -12.1% on Jun 30, 2024.

Back to Top